Phillies’ Daniel Robert Faces New Health Scare at Spring Training

Phillies’ Daniel Robert Faces New Health Scare at Spring Training

Clearwater, Fla. — Daniel Robert, a 31-year-old right-handed reliever in the Phillies organization, suffered a second troubling health episode during spring work at the team’s Clearwater complex. The latest collapse occurred during his first bullpen session of the spring. Medical staff responded immediately.

Details of the spring incident

Robert was throwing a bullpen while rookie Andrew Painter pitched nearby. Manager Rob Thomson watched from close by.

After his final pitch, Robert staggered and fell to one knee. His legs gave out and he collapsed onto his back.

Medical response and condition

Team trainers and coaches rushed to assist. An implantable cardioverter defibrillator activated as he left the mound.

Robert remained alert and communicative. He was taken to a local hospital for device data review and released later that day.

Previous Halloween event

The club said a similar collapse occurred on Halloween. Trainers used CPR and a defibrillator during that earlier emergency.

Robert had credited the team’s quick actions with saving his life after that episode.

Team perspective and reactions

Painter described Robert as upbeat and positive in the clubhouse. The rookie noted Robert felt fine before and during the session.

Thomson called the on-field collapse frightening and praised the immediate medical response.

Career implications

Robert spent much of the 2025 season at Triple-A. He made 15 appearances for the major-league club that year.

He re-signed with the Phillies last month on a minor-league contract. His future with the organization is now uncertain.

Context from teammates

  • Painter and Robert were teammates with Triple-A Lehigh Valley.
  • Teammates left the area while trainers treated Robert.
  • Emergency vehicles arrived as trainers worked on the mound.

Filmogaz.com will continue to follow Robert’s condition and the club’s updates. Coverage will track any impact on roster plans and medical findings related to the implantable device.